Part 1: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Ascending Single Dose and Food Influence Study of QGC001 Administered Orally To Healthy Adult Subjects, Part 2: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Ascending Multiple Dose Study of QGC001 Administered Orally To Healthy Adult Subjects.

Trial Profile

Part 1: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Ascending Single Dose and Food Influence Study of QGC001 Administered Orally To Healthy Adult Subjects, Part 2: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Ascending Multiple Dose Study of QGC001 Administered Orally To Healthy Adult Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Oct 2014

At a glance

  • Drugs QGC 001 (Primary)
  • Indications Essential hypertension
  • Focus Adverse reactions
  • Sponsors Quantum Genomics
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 18 Jul 2013 New source identified and integrated: ClincalTrials.gov record.
    • 18 Jul 2013 Status changed from recruiting to completed, as reported by the ClincialTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top